Retractable Technologies, Inc. (NYSE:RVP) CEO Acquires $14,360.58 in Stock

Retractable Technologies, Inc. (NYSE:RVP) CEO Thomas J. Shaw bought 18,411 shares of the stock in a transaction that occurred on Monday, January 6th. The stock was bought at an average cost of $0.78 per share, for a total transaction of $14,360.58. Following the completion of the purchase, the chief executive officer now directly owns 14,947,978 shares of the company’s stock, valued at $11,659,422.84. This represents a 0.12 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.

Retractable Technologies Stock Down 7.7 %

RVP opened at $0.75 on Thursday. The company has a quick ratio of 5.92, a current ratio of 8.57 and a debt-to-equity ratio of 0.01. The business’s fifty day simple moving average is $0.66 and its 200 day simple moving average is $0.85. Retractable Technologies, Inc. has a 52 week low of $0.56 and a 52 week high of $1.34. The stock has a market cap of $22.52 million, a PE ratio of -1.39 and a beta of 1.94.

Hedge Funds Weigh In On Retractable Technologies

An institutional investor recently bought a new position in Retractable Technologies stock. PFG Investments LLC bought a new position in Retractable Technologies, Inc. (NYSE:RVP) in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 34,600 shares of the company’s stock, valued at approximately $27,000. PFG Investments LLC owned approximately 0.12% of Retractable Technologies at the end of the most recent reporting period. Hedge funds and other institutional investors own 7.58% of the company’s stock.

Analysts Set New Price Targets

Separately, StockNews.com assumed coverage on shares of Retractable Technologies in a report on Monday. They issued a “hold” rating on the stock.

Retractable Technologies Company Profile

Retractable Technologies, Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes.